Evidence map›Paper›PMID 23312429›Full record

Trial reportBehavior therapy2013

Attributions of change and self-efficacy in a randomized controlled trial of medication and psychotherapy for problem drinking.

Katherine Schaumberg, Alexis Kuerbis, Jon Morgenstern, Frederick Muench

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Behavior therapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Katherine SchaumbergColumbia University Medical Center. KS741289@albany.edu
Alexis Kuerbis
Jon Morgenstern
Frederick Muench
Columbia University Irving Medical Center · US

Funding

Naltrexone and CBT for problem drinkingR01AA015553 · NIAAA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI MORGENSTERN, JON · 2006 to 2010
$3.0M
NIAAA NIH HHS R01 AA0115553-01NIAAA NIH HHS R01 AA015553
6 · The paper itself

Abstract

The current study examines participants' attributions of change in a double-blind, randomized controlled trial of problem drinkers wanting to moderate their alcohol consumption. Participants were assigned to 12 weeks of naltrexone or placebo, which was paired with either combined motivational interviewing and cognitive behavioral therapy (MBSCT) along with an enhanced medication management intervention or enhanced medication management only. Upon treatment completion, a questionnaire assessed participants' attributions of change along with their self-efficacy in their ability to maintain treatment gains. Participants differed in strength of attributions of change and self-efficacy according to both their therapy condition and their hypothesized medication condition. Specifically, those in the MBSCT condition who hypothesized that they received placebo displayed greater confidence in continuing changes without medication compared with the other groups. How treatment condition and attributions of change relate to self-efficacy for long-term maintenance of treatment gains are discussed.

Indexed as

Self EfficacyAdolescentAdultAgedAlcoholismCognitive Behavioral TherapyCombined Modality TherapyDouble-Blind MethodHomosexuality, MaleHumansMaleMiddle AgedMotivational InterviewingNaltrexoneNarcotic AntagonistsTreatment OutcomeNaltrexoneNarcotic Antagonists

Identifiers

PMID23312429
PMCPMC3556396
OpenAlexW2066298934

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.